bpc-157 germany legal status bfarm FDA Approval Status: Is It Approved for Human Use? WADA's 2022 Prohibited List now
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] Lin J
Severe Anemia Risks: In people with severe megaloblastic anemia, aggressive treatment can cause low potassium (hypokalemia) and sudden, serious complications
BPC-157 significantly alleviated liver damage caused by celecoxib, which induced the injury
especially during the healing period
